Recommended monitoring schedule for patients on rosuvastatin who start Zepbound: Baseline (before first Zepbound injection): Fasting lipid panel, CK, hepatic transaminases
Protocols should specify how long reconstituted solutions remain stable, how waste is disposed of, and how data will be recorded to prevent selective reporting
Whether you choose compounded semaglutide, tirzepatide, or a microdose protocol, pairing medication with your genetic insights and working closely with your provider on behavior change and monitoring sets you up for better long-term weight stability and reduced rebound risk
In summary, as Kerckhove et al
ChIP assays showed that, in contrast to WT ACTL6A, the ACTL6A HR-deletion mutant exhibited no restorative effect on the binding of NRF2 with the promoter of GCLC (Fig